Q1 Earnings Forecast for MGRM Issued By Zacks Small Cap

Monogram Orthopaedics, Inc. (NASDAQ:MGRM - Free Report) - Investment analysts at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics in a report released on Thursday, March 13th. Zacks Small Cap analyst T. Kerr anticipates that the company will post earnings per share of ($0.10) for the quarter. The consensus estimate for Monogram Orthopaedics' current full-year earnings is ($0.49) per share. Zacks Small Cap also issued estimates for Monogram Orthopaedics' Q2 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.44) EPS and FY2026 earnings at ($0.16) EPS.

Several other equities research analysts have also issued reports on MGRM. Roth Mkm increased their target price on shares of Monogram Orthopaedics from $4.00 to $5.40 and gave the stock a "buy" rating in a research note on Tuesday. Roth Capital set a $5.40 target price on shares of Monogram Orthopaedics in a research note on Tuesday.

Monogram Orthopaedics Stock Down 8.9 %

Shares of MGRM stock traded down $0.30 during mid-day trading on Monday, hitting $3.06. 239,614 shares of the stock were exchanged, compared to its average volume of 288,256. The firm has a fifty day moving average of $2.60 and a 200 day moving average of $2.50. Monogram Orthopaedics has a 52-week low of $1.53 and a 52-week high of $4.90. The company has a market cap of $107.98 million, a PE ratio of -6.49 and a beta of 1.66.

Remove Ads

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last announced its quarterly earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.03.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Barclays PLC purchased a new position in Monogram Orthopaedics in the 3rd quarter valued at about $29,000. State Street Corp purchased a new position in Monogram Orthopaedics in the 3rd quarter valued at about $62,000. Geode Capital Management LLC lifted its stake in Monogram Orthopaedics by 1,267.4% in the 3rd quarter. Geode Capital Management LLC now owns 210,144 shares of the company's stock worth $557,000 after purchasing an additional 194,776 shares in the last quarter. Jane Street Group LLC purchased a new position in Monogram Orthopaedics in the 4th quarter worth approximately $25,000. Finally, Northern Trust Corp lifted its stake in Monogram Orthopaedics by 110.6% in the 4th quarter. Northern Trust Corp now owns 45,873 shares of the company's stock worth $109,000 after purchasing an additional 24,088 shares in the last quarter. 0.45% of the stock is owned by hedge funds and other institutional investors.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.